Does antimicrobial triclosan-coated PDS PLUS for skin closure reduce surgical site infections? A controlled clinical trial of class II abdominal surgeries.

Does antimicrobial triclosan-coated PDS PLUS for skin closure reduce surgical site infections? A controlled clinical trial of class II abdominal surgeries. - A controlled clinical trial of antimicrobial triclosan-coated PDS PLUS

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000021892

Enrollment

146

Registered

2016-04-20

Start date

2013-05-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

class II abdominal surgeries.

Interventions

Absorbable monofilament subcutaneous closure PDS PLUS subcutaneous closure

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Class II abdominal surgeries

Exclusion criteria

Exclusion criteria: General peritonitis, intestinal perforation, prior infectious disease of abdominal cavity

Design outcomes

Primary

Measure	Time frame
SSI rate	—

Secondary

Measure	Time frame
risk factors of SSI	—

Countries

Japan

Contacts

Public ContactUmemura Akira

Morioka Municipal Hospital Department of Surgery

auau001@hotmail.com019-635-0101

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026